search
Back to results

Comparative Evaluation of Chlorhexidine, Metronidazole and Combination Gels on Gingivitis

Primary Purpose

Gingivitis

Status
Unknown status
Phase
Phase 3
Locations
Pakistan
Study Type
Interventional
Intervention
Metronidazole gel
Chlorhexidine Gluconate
Sponsored by
Aga Khan University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Gingivitis

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Patients having 20 or more healthy teeth
  • Systematically healthy patient with no co-morbid
  • Subjects with clinically confirmed gingivitis having positive bleeding gums on probing in every sextant
  • Subjects having teeth without any clinical attachment loss

Exclusion criteria:

  • Subjects with clinical attachment loss of greater than 2 mm on two sites
  • Pregnant or lactating females
  • Subjects with removal or fixed dental prosthesis
  • History of surgical or nonsurgical periodontal therapy in the last 6 months
  • Use of antibiotic in the last 30 days
  • Habit of smoking or use of smokeless tobacco
  • Allergic to Metronidazole or Chlorhexidine
  • Presence of any craniofacial syndrome patients
  • Patients on medications that have effects on gingival conditions (such as Nifedipine, Cyclosporine and Phenytoin etc.

Sites / Locations

  • Aga Khan UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Active Comparator

Arm Label

Group A

Group B

Group C

Arm Description

subjects will be instructed to apply a standard 0.2 % Chlorhexidine gel (clinica gel) on the marginal gingiva for the next 14 days, twice a day for 30 minutes, after morning and evening tooth brushing

Subjects will be instructed to apply 0.8 % Metronidazole gel (anaerobic gel) twice daily for 30 minutes after morning and evening tooth brushing for two weeks

subjects will be instructed to apply 0.2 % Chlorhexidine gel (clinica gel) on the marginal gingiva after morning tooth brushing for 30 minutes and 0.8 % metronidazole gel (anaerobic gel) after evening tooth brushing for 30 minutes for two weeks. Subjects in these groups will receive the detailed and precise instruction and demonstrations on the diurnal alternate application of the two gels

Outcomes

Primary Outcome Measures

Change in Gingival Index
On each appointment, gingival index values will be evaluated and change in the gingival index will be noted.

Secondary Outcome Measures

Change in Oral Hygiene Index
Change in Bleeding index
Change in Probing depth

Full Information

First Posted
April 28, 2017
Last Updated
May 4, 2017
Sponsor
Aga Khan University
search

1. Study Identification

Unique Protocol Identification Number
NCT03142607
Brief Title
Comparative Evaluation of Chlorhexidine, Metronidazole and Combination Gels on Gingivitis
Official Title
Comparative Evaluation of Chlorhexidine, Metronidazole and Combination Gels on Gingivitis: A Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
May 2017
Overall Recruitment Status
Unknown status
Study Start Date
February 3, 2017 (Actual)
Primary Completion Date
January 2, 2018 (Anticipated)
Study Completion Date
February 2, 2018 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Aga Khan University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Patient presenting to the dental clinic with gingivitis and fulfilling the inclusion criteria will be included in the study after taking informed consent. Participants will be divided into three groups. Each group will be instructed to apply metronidazole gel, chlorhexidine gel or combination of metronidazole and chlorhexidine gel on the marginal gingiva. Measurement for the gingival index will be taken at baseline, at 2 weeks and at 4 weeks interval
Detailed Description
Training of the examiner: Participating investigators(Resident and supervisor) will be trained and calibrated on the development of the trial, case selection, measurement techniques, sample collection, data compilation sheets and their precise role in the study. In order to evaluate the intra-examiner reliability, five subjects not involved in the study will be evaluated twice by each investigator for the measurements at the interval of one week. Methodology: On the first visit after clinical examination, the specially designed baseline study proforma will be filled-in. The bleeding sites, probing depth and the gingival index score will be calculated. Group A subjects will be instructed to apply a standard 0.2 % Chlorhexidine gel (clinica gel) on the marginal gingiva for the next 14 days, twice a day for 30 minutes, after morning and evening tooth brushing. Group B subjects will be instructed to apply 0.8 % Metronidazole gel (anaerobic gel) twice daily for 30 minutes after morning and evening tooth brushing for two weeks. Group C subjects will be instructed to apply 0.2 % Chlorhexidine gel (clinica gel) on the marginal gingiva after morning tooth brushing for 30 minutes and 0.8 % metronidazole gel (anaerobic gel) after evening tooth brushing for 30 minutes for two weeks. Subjects in these groups will receive the detailed and precise instruction and demonstrations on the diurnal alternate application of the two gels. The application of the topical gels will be halted after 2 weeks and second clinical examination will be carried out for bleeding sites, probing depth and the gingival index score. Scaling & polishing of teeth in all three groups and oral hygiene instructions will be reinforced. Subjects will be recalled at 4 week for evaluation of gingival and oral hygiene indices. The reading will be recorded in the study proforma. Randomization, blinding and treatment allocation: Subjects will be assigned to one of the three study groups using a computer generated randomization list. The recruitment of the patients will be performed by one investigator. All the measurements at the baseline and follow ups will be performed by the second investigator. Patient, the operator (until the gel will be handed over by the dental assistant), the investigator who is taking the measurement and the statistician will be blinded about the intervention groups. This will be ensured by giving codes to the intervention groups only known to the principal investigator who is not involved in the measurement and interaction with the patient.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gingivitis

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Factorial Assignment
Model Description
Group A has Metronidazole gel Group B has Chlorhexidene gel Group C has combination of metronidazole and chlorhexidene gel
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
Subjects will be assigned to one of the three study groups using a computer generated randomization list. The recruitment of the patients will be performed by one investigator. All the measurements at the baseline and follow ups will be performed by the second investigator. Patient, the care provider, the investigator who is taking the measurement and the statistician will be blinded about the intervention groups. This will be ensured by giving codes to the intervention groups only known to the principal investigator who is not involved in the measurement and interaction with the patient.
Allocation
Randomized
Enrollment
90 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Group A
Arm Type
Active Comparator
Arm Description
subjects will be instructed to apply a standard 0.2 % Chlorhexidine gel (clinica gel) on the marginal gingiva for the next 14 days, twice a day for 30 minutes, after morning and evening tooth brushing
Arm Title
Group B
Arm Type
Active Comparator
Arm Description
Subjects will be instructed to apply 0.8 % Metronidazole gel (anaerobic gel) twice daily for 30 minutes after morning and evening tooth brushing for two weeks
Arm Title
Group C
Arm Type
Active Comparator
Arm Description
subjects will be instructed to apply 0.2 % Chlorhexidine gel (clinica gel) on the marginal gingiva after morning tooth brushing for 30 minutes and 0.8 % metronidazole gel (anaerobic gel) after evening tooth brushing for 30 minutes for two weeks. Subjects in these groups will receive the detailed and precise instruction and demonstrations on the diurnal alternate application of the two gels
Intervention Type
Drug
Intervention Name(s)
Metronidazole gel
Other Intervention Name(s)
Revomet gel
Intervention Description
1% Metronidazole gel
Intervention Type
Drug
Intervention Name(s)
Chlorhexidine Gluconate
Other Intervention Name(s)
Clinica gel
Intervention Description
0.2% Chlorhexidene gluconate gel
Primary Outcome Measure Information:
Title
Change in Gingival Index
Description
On each appointment, gingival index values will be evaluated and change in the gingival index will be noted.
Time Frame
Two weeks and four weeks
Secondary Outcome Measure Information:
Title
Change in Oral Hygiene Index
Time Frame
Two weeks and four weeks
Title
Change in Bleeding index
Time Frame
Two weeks and four weeks
Title
Change in Probing depth
Time Frame
Two weeks and four weeks

10. Eligibility

Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Patients having 20 or more healthy teeth Systematically healthy patient with no co-morbid Subjects with clinically confirmed gingivitis having positive bleeding gums on probing in every sextant Subjects having teeth without any clinical attachment loss Exclusion criteria: Subjects with clinical attachment loss of greater than 2 mm on two sites Pregnant or lactating females Subjects with removal or fixed dental prosthesis History of surgical or nonsurgical periodontal therapy in the last 6 months Use of antibiotic in the last 30 days Habit of smoking or use of smokeless tobacco Allergic to Metronidazole or Chlorhexidine Presence of any craniofacial syndrome patients Patients on medications that have effects on gingival conditions (such as Nifedipine, Cyclosporine and Phenytoin etc.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Robia Ghafoor, BDS, FCPS
Phone
00922134864374
Email
robia.ghafoor@aku.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Sheikh Bilal Badar, BDS
Phone
00923452388775
Email
sbilalbadar@gmail.com, sheikh.badar@aku.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Robia Ghafoor, BDS, FCPS
Organizational Affiliation
Aga Khan University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Aga Khan University
City
Karachi
State/Province
Sindh
ZIP/Postal Code
74800
Country
Pakistan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Robia Ghafoor, BDS, FCPS
Phone
00922134864374
Email
robia.ghafoor@aku.edu
First Name & Middle Initial & Last Name & Degree
Sheikh Bilal Badar, BDS
Phone
00923452388775
Email
sbilalbadar@gmail.com, sheikh.badar@aku.edu

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Comparative Evaluation of Chlorhexidine, Metronidazole and Combination Gels on Gingivitis

We'll reach out to this number within 24 hrs